Tri Locum Partners Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$712.5M
Q ending 2026-03-31
Prior quarter
$770.1M
Q ending 2025-12-31
Change
-7.5% QoQ · +265.6% YoY
Positions
17
reported holdings
Largest positions
All 17 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Shares | $101.3M | 415K |
| Intuitive Surgical Inc | ISRG | Shares | $70.6M | 153K |
| Thermo Fisher Scientific Inc | TMO | Shares | $65.1M | 132K |
| Ascendis Pharma A/S | Shares | $58.4M | 255K | |
| Vertex Pharmaceuticals Inc | VRTX | Shares | $57.7M | 129K |
| Eli Lilly & Co | LLY | Shares | $56.8M | 62K |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $54.1M | 103K |
| Dexcom Inc | DXCM | Shares | $43.8M | 698K |
| United Therapeutics Corp Del | UTHR | Shares | $41.7M | 70K |
| Nuvalent Inc | 5AX | Shares | $31.6M | 309K |
| Teva Pharmaceutical Inds Ltd | TEVA | Shares | $30.8M | 1.0M |
| Jazz Pharmaceuticals Plc | Shares | $30.0M | 159K | |
| Argenx Se | ARGX | Shares | $23.1M | 32K |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $17.7M | 253K |
| Dianthus Therapeutics Inc | DNTH | Shares | $12.2M | 146K |
| Axsome Therapeutics Inc. | AXSM | Shares | $10.5M | 62K |
| Definium Therapeutics Inc | DFTX | Shares | $7.0M | 370K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.